1. Gelenberg AJ, Gibson CJ. Tyrosine for the treatment of depression. Nutrition and health. 1984;3(3):163-73.
2. Blum K, Cull JG, Chen TJ, Garcia-Swan S, Holder JM, Wood R, et al. Clinical evidence for effectiveness of Phencal™ in maintaining weight loss in an open-label, controlled, 2-year study. Current therapeutic research. 1997;58(10):745-63.
3. Blum K, Febo M, D Badgaiyan R, R Braverman E, Dushaj K, Li M, et al. Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. Current pharmaceutical design. 2016;22(38):5837-54.
4. Blum K, Febo M, Fried L, Baron D, Braverman ER, Dushaj K, et al. Pro-Dopamine Regulator–(KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). Journal of reward deficiency syndrome and addiction science. 2017;3(1):3.
5. Owasoyo JO, Neri DF, Lamberth JG. Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviation, space, and environmental medicine. 1992.
6. Neri DF, Wiegmann D, Stanny RR, Shappell SA, McCardie A, McKay DL. The effects of tyrosine on cognitive performance during extended wakefulness. Aviation, space, and environmental medicine. 1995.
7. Banderet LE, Lieberman HR. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans. Brain research bulletin. 1989;22(4):759-62.
8. Deijen J, Orlebeke J. Effect of tyrosine on cognitive function and blood pressure under stress. Brain research bulletin. 1994;33(3):319-23.
9. Leyton M, Young S, Blier P, Baker G, Pihl R, Benkelfat C. Acute tyrosine depletion and alcohol ingestion in healthy women. Alcoholism: Clinical and Experimental Research. 2000;24(4):459-64.
10. Watson RR, Watzl B. Nutrition and Alcoholthe CRC Series in Physiology of Drug Abuse: CRC Press; 1992.
11. Nesic J, Duka T. Effects of stress and dietary tryptophan enhancement on craving for alcohol in binge and non-binge heavy drinkers. Behavioural pharmacology. 2014;25:503.
13. Jukić T, Rojc B, Boben-Bardutzky D, Hafner M, Ihan A. The use of a food supplementation with D-phenylalanine, L-glutamine and L-5-hydroxytriptophan in the alleviation of alcohol withdrawal symptoms. Collegium antropologicum. 2011;35(4):1225-30.
14. Brousse G, Arnaud B, Vorspan F, Richard D, Dissard A, Dubois M, et al. Alteration of glutamate/GABA balance during acute alcohol withdrawal in emergency department: a prospective analysis. Alcohol and alcoholism. 2012;47(5):501-8.
15. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Advances in pharmacology. 1996;38:601-28.
16. Lieber CS. S-adenosyl-L-methionine: its role in the treatment of liver disorders. The American journal of clinical nutrition. 2002;76(5):1183S-7S.
17. Anstee QM, Day CP. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. Journal of hepatology. 2012;57(5):1097-109.
18. Gundermann K-J, Kuenker A, Kuntz E, Droździk M. Activity of essential phospholipids (EPL) from soybean in liver diseases. Pharmacological Reports. 2011;63(3):643-59.
19. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcoholism: Clinical and Experimental Research. 2003;27(11):1765-72.
20. Peters T, Kotowicz J, Nyka W, Kozubski W, Kuznetsov V, Vanderbist F, et al. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial. Alcohol and alcoholism. 2006;41(6):636-42.
21. Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Colditz GA, et al. A prospective study of folate intake and the risk of breast cancer. Jama. 1999;281(17):1632-7.
22. Shils ME, Shike M. Modern nutrition in health and disease: Lippincott Williams & Wilkins; 2006.
23. US Department Of Health Services. Folate Dietary Supplement Fact Sheet – For Health Professionals. April 20, 2016.
24. Taylor MJ, Carney SM, Geddes J, Goodwin G. Folate for depressive disorders. The Cochrane Library. 2003.
26. Li F, Duan K, Wang C, McClain C, Feng W. Probiotics and alcoholic liver disease: treatment and potential mechanisms. Gastroenterology research and practice. 2016;2016.
27. Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol. 2008;42(8):675-82.
28. Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). The Journal of Alternative and Complementary Medicine. 2014;20(12):901-8.
29. Kim, H., et al. Journal Of Ethnopharmacology. A standardized extract of the fruit of Hovenia dulcis alleviated alcohol-induced hangover in healthy subjects with heterozygous ALDH2: A randomized, controlled, crossover trial. September 2017.
30. Blum, K., et al. Allelic association of human dopamine D2 receptor gene in alcoholism. Journal Of The American Medical Association. April 1990;263(15):2055-60.
31. Volkow et al. Imaging dopamine’s role in drug abuse and addiction. Journal of Neuropharmacology. 2009;56 Suppl 1:3-8. doi: 10.1016/j.neuropharm.2008.05.022. Epub 2008 Jun 3.
32. Ghorbani Z, Hajizadeh M, Hekmatdoost A. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence. Hepatobiliary Pancreat Dis Int. 2016 Aug;15(4):348-60.
33. Blum, K., et al. The Benefits of Customized DNA Directed Nutrition To Balance The Brain Reward Circuitry And Reduce Addictive Behaviors. Precis Med (Bangalore). 2016; 1(1): 18–33.
34. Mohammad, M, et al. Zinc And Liver Disease. Nutrition in Clinical Practice 27(1):8-20 · February 2012
35. Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord. 2009 Nov;118(1-3):187-95. doi: 10.1016/j.jad.2009.02.014. Epub 2009 Mar 10.
36. Collins MA. Alcohol abuse and docosahexaenoic acid: Effects on cerebral circulation and neurosurvival. Brain Circ 2015;1:63-8